Effect of metformin on apoptosis induction in ovarian cancer cells

Effect of metformin on apoptosis induction in ovarian cancer cells

Introduction: Ovarian cancer is one of the most difficult problems in gynecologic oncology and the search for new drugs effective in the treatment of this kind of cancer, especially in cases resistant to current forms of therapy, remains a challenging priority. The aim of the study was to analy...

Full description

Bibliographic Details
Main Authors:	Aneta Rogalska, Ewa Forma, Piotr Ciesielski, Magdalena Bryś, Anna Krześlak, Agnieszka Marczak
Format:	Article
Language:	English
Published:	Termedia Publishing House 2014-06-01
Series:	Menopause Review
Subjects:	metformin ovarian cancer SKOV-3 apoptosis <i>BIRC5</i> survivin
Online Access:	http://www.termedia.pl/Effect-of-metformin-on-apoptosis-induction-in-ovarian-cancer-cells,4,23056,1,1.html

Similar Items

Metformin Affects Olaparib Sensitivity through Induction of Apoptosis in Epithelial Ovarian Cancer Cell Lines
by: Patrycja Gralewska, et al.
Published: (2021-09-01)

Polymorphism of Baculoviral Inhibitor of Apoptosis Repeat-Containing 5 (BIRC5) Can Be Associated with Clinical Outcome of Non-Small Cell Lung Cancer
by: Michał Szczyrek, et al.
Published: (2022-03-01)

Inhibition of Survivin Homodimerization Decreases Neuroblastoma Cell Growth
by: Carmen Dorneburg, et al.
Published: (2023-12-01)

Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells
by: Maritza P. Garrido, et al.
Published: (2020-10-01)

An Insight into Survivin in Relevance to Hematological, Biochemical and Genetic Characteristics in Tobacco Chewers with Oral Squamous Cell Carcinoma
by: Susanna Theophilus Yesupatham, et al.
Published: (2023-05-01)

Ablation of Survivin in T Cells Attenuates Acute Allograft Rejection after Murine Heterotopic Heart Transplantation by Inducing Apoptosis
by: Heng Xu, et al.
Published: (2021-08-01)

<i>BIRC5</i>/Survivin Expression as a Non-Invasive Biomarker of Endometriosis
by: Carolina Filipchiuk, et al.
Published: (2020-07-01)

Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?
by: Fengzhi Li, et al.
Published: (2019-08-01)

Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients
by: Franziska Büscheck, et al.
Published: (2020-02-01)

Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
by: Anna Fäldt Beding, et al.
Published: (2022-03-01)

Alantolactone and ZnO nanoparticles induce apoptosis activity of cisplatin in an ovarian cancer cell line (SKOV3)
by: Shahriar Alipour, et al.
Published: (2022-01-01)

Berberine enhances the sensitivity of radiotherapy in ovarian cancer cell line (SKOV-3)
by: Mohammed S. Aleissa, et al.
Published: (2023-01-01)

Exosomes biogenesis was increased in metformin-treated human ovary cancer cells; possibly to mediate resistance
by: Reza Abbasi, et al.
Published: (2024-04-01)

<i>BIRC5</i> Gene Polymorphisms Are Associated with a Higher Stage of Local and Regional Disease in Oral and Oropharyngeal Squamous Cell Carcinomas
by: Ivan Mumlek, et al.
Published: (2023-12-01)

Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts
by: Nina Oparina, et al.
Published: (2021-05-01)

Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of <i>KRT5</i>, <i>KRT20</i>, and <i>ERBB2</i> in Muscle-Invasive Bladder Cancer Treated by Adjuvant Chemotherapy
by: Thorsten H. Ecke, et al.
Published: (2020-10-01)

Genetic polymorphisms and epigenetic regulation of survivin encoding gene, BIRC5, in multiple sclerosis patients
by: Dariush Rahban, et al.
Published: (2019-08-01)

Evaluation of Antagonistic Effects of Metformin with Cisplatin in Gastric Cancer Cells
by: Vahid Lesan, et al.
Published: (2014-09-01)

YM155-Adapted Cancer Cell Lines Reveal Drug-Induced Heterogeneity and Enable the Identification of Biomarker Candidates for the Acquired Resistance Setting
by: Martin Michaelis, et al.
Published: (2020-04-01)

Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells
by: Marina Conde, et al.
Published: (2017-12-01)

miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5
by: Chao Yuan, et al.
Published: (2021-07-01)

Evaluating the Potential Anticancer Properties of <i>Salvia triloba</i> in Human-Osteosarcoma U2OS Cell Line and Ovarian Adenocarcinoma SKOV3 Cell Line
by: Naela Adel Mohammed Saleh, et al.
Published: (2022-11-01)

Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
by: Felisiak-Golabek Anna, et al.
Published: (2011-11-01)

The abnormal expression of chromosomal region maintenance 1 (CRM1)-survivin axis in ovarian cancer and its related mechanisms regulating proliferation and apoptosis of ovarian cancer cells
by: Jing Zhang, et al.
Published: (2022-01-01)

Clinical Implication of Metformin in Relation to Diabetes Mellitus and Ovarian Cancer
by: Santosh Kumar Singh, et al.
Published: (2021-08-01)

Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets
by: Silvia Vivarelli, et al.
Published: (2020-09-01)

Knockout Of BIRC5 Gene By CRISPR/Cas9 Induces Apoptosis And Inhibits Cell Proliferation In Leukemic Cell Lines, HL60 And KG1
by: Narimani M, et al.
Published: (2019-11-01)

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
by: Marzieh Farimani Sanoee, et al.
Published: (2011-06-01)

Laparoscopic Ovarian Drilling in Metformin and Clomiphene Resistant Women with Polycystic Ovarian Syndrome
by: Soheila Arefi, et al.
Published: (2008-03-01)

Metformin and phenethyl isothiocyanate combined treatment <it>in vitro</it> is cytotoxic to ovarian cancer cultures
by: Chan Daniel K, et al.
Published: (2012-07-01)

Ginger inhibits the invasion of ovarian cancer cells SKOV3 through CLDN7, CLDN11 and CD274 m6A methylation modifications
by: Xiaoyu Zhang, et al.
Published: (2024-04-01)

Prognostic Significance of Survivin Expression in Patients with Ovarian Carcinoma: A Meta-Analysis
by: Beata Gąsowska-Bajger, et al.
Published: (2021-02-01)

Discovery of potential targets of Triptolide through inverse docking in ovarian cancer cells
by: Qinhang Wu, et al.
Published: (2020-03-01)

Antitumor Effect of Metformin on Ovarian Cancer Cells
by: YU Hui, et al.
Published: (2024-01-01)

Metformin Affects the Transcriptomic Profile of Chicken Ovarian Cancer Cells
by: Lalitha Gopalan, et al.
Published: (2021-12-01)

Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma
by: Christian Vay, et al.
Published: (2022-07-01)

TET3- and OGT-Dependent Expression of Genes Involved in Epithelial-Mesenchymal Transition in Endometrial Cancer
by: Piotr Ciesielski, et al.
Published: (2021-12-01)

Effect of miR-581 on Autophagy of Ovarian Cancer SKOV3 Cells by Regulating FOXO1
by: GAO Haining, et al.
Published: (2022-05-01)

Comparison of Metformin and Orlistat in Anovulatory, Overweight and Obese Women with Polycystic Ovarian Syndrome
by: Uzma Gul, et al.
Published: (2023-06-01)

Is Reducing Ovarian Volume in Polycystic Ovarian Syndrome Patients after Administration of Metformin Associated with Improving Cardiovascular Risk Factors?
by: Mohsen Gharakhani, et al.
Published: (2011-07-01)